AI-Driven Target & Drug Discovery Platform
Accelerate target identification, modality-specific design, and hit-to-lead optimization with agentic AI workflows built for biotech R&D teams.
Platform Overview
A unified ecosystem combining:
CORE MODULES
Small Molecules Platform
What it enables
- Covalent & non-covalent inhibitors
- GPCRs, kinases, ion channels
- Enzymes & nuclear receptors
- Allosteric & cryptic pocket targeting
- SAR automation and prioritization
- Full ADMET property optimization
- Selectivity scoring vs isoforms/mutants
AI Capabilities
- Docking
- Binding site detection
- Virtual screening
- Selectivity + off-target prediction
- Lead optimization scoring
CORE MODULES
Peptide Platform
What it enables
- Linear / cyclic / hybrid peptides
- Non-natural amino acids
- Phage/RNA display integration
- Optimization for permeability & oral availability
- Peptide → small-molecule conversion workflows
AI Capabilities
- Sequence-to-structure prediction
- Activity prediction
- Stability modeling
- Generative peptide design
CORE MODULES
Proximity Inducers Platform (PROTACs, glues, disruptors)
What it enables
- Ternary complex prediction
- Molecular glues & degraders
- PPI disruptors
- Native + induced PPI targeting
- Membrane supramolecular assemblies
- Multi-modality workflows
AI Capabilities
- PPI interface prediction
- Ligand-induced complex assembly
- Generative designs for degraders/disruptors
Discover More Related Case Studies
Trusted by Industry Leaders:
01
Level 1 – AI-Orchestrated R&D Strategy
- Validated AI-generated drug discovery strategies
- Automated project plans & risk evaluation
- Expert-guided iterative optimization
- Dynamic adaptation during experimental cycles
02
Level 2 – Drug Discovery Workflows
- End-to-end workflows for each modality
- Tailored for biological mechanism & therapeutic class
- Integrated computational + experimental loop
- Workflow components adapt as data grows
03
Level 3 – Predictive & Generative AI Stack
- DockX – AI docking engine (small molecules + peptides)
- BindFormer – binding + affinity prediction (all modalities)
- PPI-Net – protein-protein interface prediction
- ADMET-Graph – 80+ endpoint ADMET predictor
- SelectaAI – selectivity & off-target engine
04
Level 4 – Data Engine
- Multi-omics data ingestion (scRNA, bulk RNA, proteomics, metabolomics)
- Experimental + public data fusion
- Automated feature engineering
- Knowledge graph augmentation
- Active learning for experiment prioritization
Didn’t find exactly what you were looking for?
Tell us what you’re building – we’ll map out the options, evaluate feasibility, and recommend the optimal technical pathway.
Get a consultationFor Whom
For early-stage biotechs
-
No internal data science team
-
Need to show investors a clear AI-R&D plan
-
Lack of validated target discovery workflows
For growth-stage & platform biotechs
-
Scaling multiple therapeutic programs
-
Fragmented data across wet/dry labs
-
Need for unified internal AI platform
For pharma & CRO R&D
-
Throughput & cost pressure
-
Reproducibility & regulatory complexity
-
Slow cycle times between experiments
Get in touch with us.
We’re here to assist you.